And that off stage between liveswe are the very best of friends. No one really dies and no one really suffers, except in the game. The game is not reality.
Beatrice Golomb, Associate Professor of Medicine at University of California, San Diego, masterfully exposes the corruption that has metastasized like a tumor throughout the pharmaceutical and medical industries, in the video above.
If you have any doubt about drug companies being riddled with conflicts of interestthose doubts will be shattered after seeing the evidence she presents.
The corruption has become so prolific that it has literally debased medical science. In the above linked Chicago Breaking News article, Dr.
Look at the data, look at science and make a decision based on science that has been published.
Unwanted Results are Not Published In order for scientific studies to happen, someone has to pay for them. The top funder for any drug trial is the pharmaceutical company that makes it, since the manufacturer is most invested in "proving" how spectacular its drug is.
Golomb uses the case of statins as an example, stating that all of the major statin studies have been funded exclusively by the drug industry. The second-highest funder of drug studies is the National Institute of Health NIHwhich is not the group of neutral government experts you may have assumed them to be.
But drug companies publish only a fraction of the studies they fund -- the ones that promote their drugs. If a study does not have findings that are favorable to its product, it is unlikely it will ever make it into a journal for publication.
In contrast, studies that have favorable findings almost always make the cut. There are simply thousands of scientific studies out there that have never been seen by you or your physician because they have been screened out by editors and reviewers who are being paid to uphold an industry agenda.
Whichever drug is manufactured by the study sponsor is the drug that comes out on top, 90 percent of the time! Given this, how can medical journals be considered unbiased? Bad Results are Submitted as Good When a scientific study has findings that cast doubt on the efficacy of a drug, oftentimes the negative findings are morphed into positive ones.
For example, inFDA officials analyzed a registry of 74 antidepressant trials, which included trials that were published and those that were not. This is what they found: Of the 36, 22 were not published at all, and 11 were published in a way that conveyed the results as though they were positive.
So, if you just went to the published literature, it would look like 94 percent of the studies were positive, when in reality only about 50 percent were positive They conveniently omitted this data along with other relevant findings from the copy of the study they submitted to the New England Journal of Medicine for publication.
The omissions were uncovered years later during the 7, Vioxx lawsuit litigations. Analyzers have had to look very carefully to determine which studies are actually duplicates because they are so cleverly disguised. Not surprisingly, trials reporting greater treatment efficacy were significantly more likely to be duplicated, according to Dr.
In one analysis of the published reports about ondansetron an anti-nausea drugthe same study was published 5 times. Follow-Up Reviews Done by Biased Experts The editorials that follow from a study, submitted by so-called unbiased experts and then published in reputable journals, are often done by non-neutral parties who have a financial tie to the drug maker.
Golomb uses the case of calcium channel blockers a type of heart medication as an example. The connection between authors declaring their support for calcium channel blockers and those not in support of them was highly statistically tied to their affiliation with the drug manufacturer -- in fact, the odds that their opinion was NOT due to their affiliation was more than 1, Ghostwriting Many of the articles that appear in medical journals purportedly written by well-known academics are actually written by unacknowledged ghostwriters on Big Pharma payroll.
Consider the example of Parke-Davis and their drug Neurontin. Parke-Davis contracted with a "medical education communication company," or MECC, which is a company paid almost exclusively by pharmaceutical companies to write articles, reviews, and letters to editors of medical journals to cast their products in a favorable light.
This was also done by Pfizer as a strategy for marketing Zoloft. Wyeth-Ayerst employed a similar ghostwriting tactic to promote its "fen-phen" diet drug, Redux. Journal Bias Medical journals are generally considered by medical practitioners to be a source of reliable information.
But medical journals are also businesses. Three editors, who agreed to discuss finances only if they remained anonymous, said a few journals that previously measured annual profits in the tens of thousands of dollars now make millions annually.
The truth is that Big Pharma has become quite adept at manipulating and brainwashing practitioners of conventional medicine. They influence the very heart and center of the most respected medical journals, creating dogma and beliefs that support the drug paradigm because it is blessed by the pinnacle of scientific integrity: Peer-reviewed medical journals contain advertisements that are almost exclusively for drugs, amidst articles that are biased toward promoting those drugs.
Pharmaceutical companies spend almost twice as much on marketing as they spend on research!BibMe Free Bibliography & Citation Maker - MLA, APA, Chicago, Harvard.
But the government pricing regulations under discussion are very different from the FDA regulations that are causing the problem. The writer of this article may oppose those regulations, and be taking them as fixed, saying that given their existence, medical prices must be controlled.
How helpful is GS4 Ethics Paper in judging real character of a candidate is an interesting case study in itself when IPS Safeer Karim cheated in Mains A collection of information resources designed to help enterprise IT professionals launch and advance their artificial intelligence, machine learning and automation initiatives.
By Lt Daniel Furseth. Today, I stopped caring about my fellow man. I stopped caring about my community, my neighbors, and those I serve.
I stopped caring today because a once noble profession has become despised, hated, distrusted, and mostly unwanted. Pharmaceuticals and corruption: a risk assessment corruption.
This essay focuses primarily on the role of government, since state intervention, particularly through regulation, is vital to the pharmaceutical sector.
pharmaceutical industry to some degree and also illuminates the need for the insti-.